More Information
Summary:The invention relates to isolated nucleic acid sequences which are expressed in cancers, especially gastrointestinal, kidney and prostate cancers, to the ir protein products and to the use of the nucleic acid and protein products for the identification and treatment of cancers.
Bibliography:Application Number: CA20052560865